CorpDev.Org
Daily News for Dealmakers
Big Deal
Permira’s Strategic Pivot to India Reshapes Asia Private Equity Landscape
In a bold restructuring of its Asia-Pacific operations, global private equity giant Permira has initiated plans to shutter its Hong Kong and Shanghai offices while consolidating regional leadership in Mumbai, according to multiple sources familiar...
Meta’s Antitrust Reckoning: How Instagram’s Founding Vision Clashed With Zuckerberg’s Growth Imperatives
In a Washington D.C. courtroom that has become ground zero for Big Tech accountability, former Instagram CEO Kevin Systrom delivered explosive testimony this week alleging that Meta CEO Mark Zuckerberg systematically starved the photo-sharing app...
OpenAI’s Strategic Pivot in AI Coding Tools: Why Anysphere Chose Independence Over Acquisition
In the hypercompetitive arena of AI-powered development tools, OpenAI's failed pursuit of Anysphere - creator of the Cursor code editor - reveals critical insights about valuation dynamics, strategic independence, and the race to dominate the $27...
Global Payments Reshapes Fintech Landscape Through Strategic Worldpay Acquisition and Issuer Solutions Divestiture
In a landmark $24.25 billion transaction announced April 17, 2025, Global Payments (NYSE: GPN) has positioned itself as the world's largest pure-play merchant acquirer through its acquisition of Worldpay from GTCR and FIS, while simultaneously...
Meta’s Antitrust Trial Exposes Zuckerberg’s Long-Standing Strategy of Acquisition Over Competition
As Meta's landmark antitrust trial enters its second week, newly revealed court documents and testimony from CEO Mark Zuckerberg have exposed the social media giant's decade-long pattern of neutralizing competitors through acquisition attempts and...
Top Jobs Currently Hiring
Thought Leadership
Private Equity
International
Tech, Media & Telecom
Financial Services
Health & Life Sciences
Merck KGaA’s Strategic $3.5 Billion Play: Acquiring SpringWorks to Revitalize Oncology Ambitions
In a move signaling renewed aggression in pharmaceutical M&A, Germany's Merck KGaA stands poised to finalize its largest therapeutic acquisition in a decade with the $3.5 billion purchase of SpringWorks Therapeutics. The deal, expected to close as...
Strategic Shifts in Pharma: Roche’s $50B U.S. Investment and the Looming Impact of Tariffs on M&A
As global trade tensions escalate under the Trump administration's tariff policies, Roche AG has emerged as a pivotal player in reshaping pharmaceutical manufacturing strategies. The Basel-based giant's recent $50 billion commitment to U.S....
UPS Consolidates Healthcare Logistics Dominance With $1.6 Billion Andlauer Acquisition
In a strategic move that reshapes North America's healthcare logistics landscape, United Parcel Service (NYSE: UPS) announced today its definitive agreement to acquire Toronto-based Andlauer Healthcare Group (TSX: AND) for CAD$2.2 billion (US$1.6...
KKR’s $1.2 Billion Bet on Biotage: Reshaping the Life Sciences Tools Landscape
In a move signaling private equity's growing appetite for life sciences infrastructure, KKR & Co. launched a $1.2 billion cash offer for Swedish separations technology leader Biotage AB on April 22, 2025. The 145 SEK per share bid represents a...
Looming Pharma Tariffs Reshape Biotech Landscape: Supply Chain Upheaval and Dealmaking Pause Send Shockwaves Through Industry
The pharmaceutical and biotechnology sectors face unprecedented disruption as President Trump's proposed 10-25% tariffs on imported drugs and medical devices threaten to upend global supply chains, delay clinical development, and freeze merger...
